HIV Neuropathy—a Review of Mechanisms, Diagnosis, and Treatment of Pain

Kaitlyn E. Egan, Gregory M. Caldwell, Maxim S. Eckmann

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations


Purpose of Review: This article is a systematic review of data from 2018 to 2020 regarding information from publications on epidemiologic, diagnostic, and therapeutic advancements in human immunodeficiency virus–associated peripheral neuropathy. Recent Findings: The epidemiology/pathology of HIV neuropathy is discussed. Diagnostics includes skin wrinkling-eutectic mixture of local anesthetic test and neurologic examinations. Therapeutic interventions include pharmacologic and nonpharmacologic management as well as self-management strategies. Summary: Peripheral neuropathy continues to affect the lives of persons living with HIV. First-line treatment with pregabalin or gabapentin for HIV neuropathic pain has limited data on adequate response. Exercise and self-management strategies may provide benefit in pain reduction. Continuing research on risk factors and biomarkers for HIV-related peripheral neuropathy will be critical for future diagnostic and therapeutic agents.

Original languageEnglish (US)
Article number55
JournalCurrent Pain and Headache Reports
Issue number8
StatePublished - Aug 2021


  • HIV
  • Human immunodeficiency virus
  • Neuropathic
  • Neuropathy
  • Pain
  • Treatment

ASJC Scopus subject areas

  • Clinical Neurology
  • Anesthesiology and Pain Medicine


Dive into the research topics of 'HIV Neuropathy—a Review of Mechanisms, Diagnosis, and Treatment of Pain'. Together they form a unique fingerprint.

Cite this